News

In honour of the presentation of the VNVA Els Borst Prize for her oeuvre, Prof Marlies Bongers is organising the symposium "menstruation in RED on the agenda" on 1 October.

In women trying to conceive, 1-3% experience repeated miscarriages. For more than 50% of these women, a cause for the miscarriages has yet to be found. New research from Maastricht University (UM) and the Maastricht University Medical Centre+ (MUMC+) shows that the immune system’s Natural Killer (NK...

The European Commission has awarded €23 million to set up a new platform for drug repurposing: the use of existing drugs in diseases other than those for which they were originally developed. In the next seven years UM will develop the platform REPO4EU (precision drug REPurpOsing for Europe)...

When breast cancer has spread to lymph nodes in the armpit, extensive imaging studies are performed and tumour characteristics are determined prior to surgical removal. Research initiated at Maastricht UMC+ aims to clarify the extent to which an accurate assessment can be made of possible responses...

Scientists and cardiologists have known for decades that once a piece of heart muscle has died, for example due to a heart attack, it will never grow back. However, a research group from Maastricht University led by Professor Leon de Windt has now shown that by tinkering with microRNAs, heart muscle...

Maastricht researchers argue that urgent measures are needed to tackle loneliness in society. Aside from their mental welfare needs, people who suffer from severe or very severe loneliness incur 40 to 50 percent higher healthcare costs up to a year later compared to people who don’t feel lonely. The...

The successful partnership the Living Lab in Ageing & Long-Term Care, initiated by Maastricht University, is being expanded. Having been joined by care organisations De Zorggroep, Proteion and Stichting Land van Horne in north and central Limburg, the partnership now covers the entire province.

An international team of scientists has discovered one of the causes of primary hypertension or high blood pressure. In addition, the team, led by researchers from Maastricht University (UM), discovered that this cause could be treated with existing and already registered drugs.

During his farewell as dean of the Faculty of Health, Medicine and Life Sciences (FHML) of Maastricht University (UM) and as vice president of the Board of Directors of Maastricht UMC+ on Friday, Prof Albert Scherpbier was awarded the highest distinction at UM, the Dr J.G.H. Tans Medal. He was also...